Atopic Dermatitis

Last Modified

Tags



Abstract

Concept set intended to identify patients with a diagnosis of atopic dermatitis to define a study cohort.

Funder(s)

Provenance

This concept set was developed for the "Effect of Dupilumab on Onset of Type 1 Disease" study (Incidence of Autoimmune Diseases in Children with Atopy Treated with Dupilumab) to define a cohort of patients with atopic disease, including atopic dermatitis.

Description

This concept set was developed by a data scientist (KH) for a study led by CHOP clinicians Dr. Jonathan Spergel and Dr. Stan Gabryszewski, which investigates dupilumab use and autoimmune diseases in patients with asthma and atopic dermatitis. The codeset was used to define a broad cohort of patients with atopic disease, including patients with atopic dermatitis. The codeset is designed for use with the PEDSnet data model.

Related Phenotype

Related Person

Related Study

Effect of Dupilumab on Onset of Type 1 Disease
Children's Hospital of Philadelphia
Study to determine whether use of the Type 2 blocker dupilumab in children with atopic dermatitis and asthma is associated with increased frequency of developing Type 1 disease.

Related Concept Set

Related Publications

Creative Commons license

Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 license.